Press "Enter" to skip to content

US biopharma AbbVie to buy Botox maker Allergan for $63 billion

US biopharmaceutical company AbbVie said Tuesday it would buy Botox-maker Allergan for about $63 billion, moving to diversify its product line as the industry faces pressure on drug prices.

Original source:

Also Read:   Doctor faces probe for prescribing condoms for stomach pain